Compare Aurobindo Pharma with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA CIPLA AUROBINDO PHARMA/
CIPLA
 
P/E (TTM) x 7.8 28.7 27.3% View Chart
P/BV x 1.9 4.0 48.1% View Chart
Dividend Yield % 0.6 0.6 100.7%  

Financials

 AUROBINDO PHARMA   CIPLA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
CIPLA
Mar-21
AUROBINDO PHARMA/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,023879 116.5%   
Low Rs333411 81.2%   
Sales per share (Unadj.) Rs422.8237.6 178.0%  
Earnings per share (Unadj.) Rs92.029.8 308.9%  
Cash flow per share (Unadj.) Rs110.042.2 260.5%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Avg Dividend yield %0.60.8 76.0%  
Book value per share (Unadj.) Rs374.3226.7 165.1%  
Shares outstanding (eoy) m585.94806.46 72.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.62.7 59.1%   
Avg P/E ratio x7.421.6 34.1%  
P/CF ratio (eoy) x6.215.3 40.4%  
Price / Book Value ratio x1.82.8 63.7%  
Dividend payout %4.316.8 25.9%   
Avg Mkt Cap Rs m397,398519,826 76.4%   
No. of employees `000NANA-   
Total wages/salary Rs m35,35032,518 108.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m247,746191,596 129.3%  
Other income Rs m3,8092,698 141.2%   
Total revenues Rs m251,555194,294 129.5%   
Gross profit Rs m81,48041,841 194.7%  
Depreciation Rs m10,55410,031 105.2%   
Interest Rs m7451,607 46.4%   
Profit before tax Rs m73,99032,901 224.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,0988,888 226.1%   
Profit after tax Rs m53,89224,013 224.4%  
Gross profit margin %32.921.8 150.6%  
Effective tax rate %27.227.0 100.6%   
Net profit margin %21.812.5 173.6%  
BALANCE SHEET DATA
Current assets Rs m198,235132,095 150.1%   
Current liabilities Rs m106,65245,916 232.3%   
Net working cap to sales %37.045.0 82.2%  
Current ratio x1.92.9 64.6%  
Inventory Days Days1968 28.4%  
Debtors Days Days527 786.3%  
Net fixed assets Rs m135,778116,277 116.8%   
Share capital Rs m5861,613 36.3%   
"Free" reserves Rs m218,713181,232 120.7%   
Net worth Rs m219,299182,844 119.9%   
Long term debt Rs m1,68412,028 14.0%   
Total assets Rs m334,013248,372 134.5%  
Interest coverage x100.321.5 467.2%   
Debt to equity ratio x00.1 11.7%  
Sales to assets ratio x0.70.8 96.2%   
Return on assets %16.410.3 158.6%  
Return on equity %24.613.1 187.1%  
Return on capital %33.817.7 191.0%  
Exports to sales %53.831.3 171.9%   
Imports to sales %16.410.9 150.2%   
Exports (fob) Rs m133,24859,951 222.3%   
Imports (cif) Rs m40,61520,911 194.2%   
Fx inflow Rs m133,24868,051 195.8%   
Fx outflow Rs m44,94620,911 214.9%   
Net fx Rs m88,30247,140 187.3%   
CASH FLOW
From Operations Rs m33,28937,552 88.6%  
From Investments Rs m5,987-23,872 -25.1%  
From Financial Activity Rs m-13,648-13,299 102.6%  
Net Cashflow Rs m25,831509 5,073.8%  

Share Holding

Indian Promoters % 48.8 14.9 328.4%  
Foreign collaborators % 3.1 22.4 13.7%  
Indian inst/Mut Fund % 37.2 37.5 99.3%  
FIIs % 21.7 22.3 97.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 62.7 76.8%  
Shareholders   329,940 208,128 158.5%  
Pledged promoter(s) holding % 24.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   J.B.CHEMICALS  GLAND PHARMA  BDH INDUS.  LINK PHARMA  GUJ.THEMIS.  



Today's Market

UltraTech Cement's Quarterly Performance, Deadline for AGR Dues Moratorium, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices extended their winning streak for the seventh straight day.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Oct 18, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - BAJAJ HEALTHCARE COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS